AI Article Synopsis
Article Abstract
Coxsackieviruses, a genus of enteroviruses in the small RNA virus family, cause fatal infectious diseases in humans. Thus far, there are no approved drugs to prevent these diseases. Human milk contains various biologically active components against pathogens. Currently, the potential activity of breast milk components against the coxsackievirus remains unclear. In our study, the inhibitory effect of 16 major human milk components was tested on coxsackievirus class A type 9 isolate (CV-A9), BUCT01; 2'-Fucosyllactose (2'-FL) was identified to be effective. Time-of-addition, attachment internalisation assays, and the addition of 2'-FL at different time points were applied to investigate its specific role in the viral life cycle. Molecular docking was used to predict 2'-FL's specific cellular targets. The initial screening revealed a significant inhibitory effect (99.97%) against CV-A9 with 10 mg/mL 2'-FL, with no cytotoxicity observed. Compared with the control group, 2'-FL blocked virus entry (85%) as well as inhibited viral attachment (48.4%) and internalisation (51.3%), minimising its infection in rhabdomyosarcoma (RD) cells. The cell pre-incubation with 2'-FL exhibited significant inhibition (73.2-99.9%). Extended incubation between cells with 2'-FL reduced CV-A9 infection (93.9%), suggesting that 2'-FL predominantly targets cells to block infection. Molecular docking results revealed that 2'-FL interacted with the attachment receptor αβ and the internalisation receptor FCGRT and βM with an affinity of -2.14, -1.87, and -5.43 kcal/mol, respectively. This study lays the foundation for using 2'-FL as a food additive against CV-A9 infections.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691179 | PMC |
| http://dx.doi.org/10.3390/ijms232213727 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Infant Fecal Fermentation Metabolites of Osteopontin and 2'-Fucosyllactose Support Intestinal Barrier Function.
J Agric Food Chem
December 2024
School of Food Science and Engineering, Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health, South China University of Technology, Guangzhou 510640, China.
In this study, we investigated the effects of infant fecal fermentation-derived metabolites of digested osteopontin (OPN) and 2'-fucosyllactose (2'-FL), either individually or in combination, on intestinal barrier function using a Caco-2/HT-29 coculture cell model. Our results suggested that the OPN/2'-FL (1:36-1:3) cofermentation metabolites improved epithelial barrier integrity by supporting the mRNA and protein expression of occludin, claudin-1, claudin-2, ZO-1, and ZO-2. All of the OPN/2'-FL treatments decreased the production of IL-1β, IL-6, and TNF-α, while the OPN/2'-FL ratio increased IL-10 production by inhibiting activation of the MyD88/IκB-α/NF-κB signaling pathway.
View Article and Find Full Text PDFMoisture sorption characteristics of crystalline and amorphous 2'-fucosyllactose, a human milk oligosaccharide.
Food Chem
December 2024
Food Technology Major, Graduate School of International Agricultural Technology, Seoul National University, Pyeongchang 25354, Republic of Korea; Institute of Food Industrialization, Institutes of Green Bio Science and Technology, Seoul National University, Pyeongchang 25354, Republic of Korea; Center for Food and Bioconvergence, Seoul National University, Seoul 08826, Republic of Korea. Electronic address:
The moisture sorption characteristics of crystalline and amorphous forms of 2'-fucosyllactose (2'-FL) were investigated and compared with those of two forms of lactose. The moisture sorption isotherms showed that, relative to crystalline α-lactose monohydrate (α-LM), crystalline 2'-FL was more susceptible to moisture sorption. Crystalline 2'-FL exhibited a lower deliquescence point (89.
View Article and Find Full Text PDFRegulation of Metabolic Pathways to Enhance Difucosyllactose Biosynthesis in .
J Agric Food Chem
December 2024
College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
Difucosyllactose (DFL), an important kind of fucosylated human milk oligosaccharides (HMOs), has garnered considerable attention due to its excellent physiological activities in infants. Previously, we achieved biosynthesis of DFL; however, substantial residual intermediates of fucosyllactoses (FL) were detected. In this study, DFL biosynthesis was optimized, and residual FL were reduced by regulating metabolic pathways.
View Article and Find Full Text PDFHuman milkoligosaccharides: Role in lactation and infant formulas.
Arch Argent Pediatr
December 2024
Instituto de Lactología Industrial (INLAIN, CONICET-UNL), Facultad de Ingeniería Química, Universidad Nacional del Litoral, Santa Fe, Argentina.
Human milk oligosaccharides (HMO) are the specific and selective growth substrate for bifidobacteria, preventing pathogen adhesion, modulating the immune system, and impacting neurodevelopment. Human milk is the best food for the neonate; infant formulas enriched with HMOs are indicated when human milk is not possible or sufficient. HMOs developed and added to available infant formulas are 2'-FL (2'-fucosyl lactose), 3-FL (3-fucosyl lactose), 3'-SL (3'-sialyl lactose), 6'-SL (6'-sialyl lactose), LNT (lacto-N-tetraose), and 3'-GL (3'-galactosyl lactose), the latter being produced in situ by microbial fermentation.
View Article and Find Full Text PDFDe novo 2'-fucosyllactose biosynthesis using glucose as the sole carbon source by multiple engineered Bacillus subtilis.
Metab Eng
December 2024
Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, Jiangnan University, Wuxi, 214122, China; Science Center for Future Foods, Jiangnan University, Wuxi, 214122, China. Electronic address:
2'-Fucosyllactose (2'-FL) is the most abundant human milk oligosaccharide and plays significant roles in gut microbiome balance, neural development, and immunoregulation. However, current fermentation schemes using multiple carbon sources increase production cost and metabolism burden. This study reported the development of an engineered Bacillus subtilis strain that produces 2'-FL using glucose as the sole carbon source.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!